Prognosis related to staging systems for chronic lymphocytic leukemia

Authors

  • José Roberto de Faria Universidade de Alfenas
  • José Salvador Rodrigues de Oliveira Universidade Federal de São Paulo
  • Rosa Malena Delbone de Faria Universidade de Alfenas
  • Maria Regina Regis Silva Universidade de Alfenas
  • Samuel Goihman Universidade Federal de São Paulo
  • Miohoko Yamamoto Universidade Federal de São Paulo
  • José Kerbauy Universidade Federal de São Paulo

Keywords:

Chronic Lymphocytic Leukemia, Prognosis, Clinical, Staging

Abstract

CONTEXT: Chronic lymphocytic leukemia (CLL) is a clonal lymphoproliferative disorder, characterized by B lymphocytic proliferation. CLL is the most frequent adult leukemia in Western countries, accounting for 25 to 30% of all white leukemic patients. OBJECTIVE: To evaluate clinical and staging characteristics in prognosis of chronic lymphocytic leukemia. DESIGN: Evaluation of clinical-staging data. SETTING: Universidade Federal de São Paulo - Escola Paulista de Medicina / Universidade de Alfenas. SAMPLE: 73 patients diagnosed from 1977 to 1994. MAIN MEASUREMENTS: Sex, ethnic origin, age, lymphadenopathy, splenomegaly, hepatomegaly, three or more areas of lymphoid enlargement, hemoglobin (g/dl), lymphocytes/mm³, Platelets/mm³ RESULTS: Mean survival of patients was 76 months, median age was 65 years, ranging from 33 to 87. Forty-four patients (60.3%) were male and 29 (39.7%) female. CONCLUSION: The Binet system determined a better prognosis than Rai.

Downloads

Download data is not yet available.

Author Biographies

José Roberto de Faria, Universidade de Alfenas

MD. Division of Hematology, Universidade de Alfenas (UNIFENAS), Minas Gerais, Brazil.

José Salvador Rodrigues de Oliveira, Universidade Federal de São Paulo

MD, PhD. Division of Hematology, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Rosa Malena Delbone de Faria, Universidade de Alfenas

MD. Division of Hematology, Universidade de Alfenas (UNIFENAS), Minas Gerais, Brazil.

Maria Regina Regis Silva, Universidade de Alfenas

MD, PhD. Division of Pathology, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Samuel Goihman, Universidade Federal de São Paulo

MD. Division of Epidemiology, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Miohoko Yamamoto, Universidade Federal de São Paulo

MD, PhD. Division of Hematology, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

José Kerbauy, Universidade Federal de São Paulo

MD, PhD, FACP. Division of Hematology, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

References

International Workshop on Chronic Lymphocytic Leukemia. Recommendation for diagnosis, staging, and response criteria. Ann Intern Med 1989;110(suppl 3):236-8.

Bartal A, Bentwich Z, Manny N, et al. Clinical aspects of chronic lymphocytic leukemia in Israel. Acta Haematol 1978;60:161-71.

Johnson LE. Chronic lymphocytic leukemia. Practical Therapeutics 1988;38(suppl 6):167-76.

Jamra M, Amaral A. A incidęncia da leucemia na zona de Săo Paulo. Rev Hosp Clin Fac Med Univ Săo Paulo 1957;12:230-3.

Rai KR, Montserrat E. Prognostic factors in chronic lymphocytic leukemia. Semin Hematol 1987;24(suppl 4):252-6.

Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia: recent progress and future directions. Blood 1975;46:219-34.

Binet JL, Auquier A, Diguiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.

Binet JL, Catovsky D, Chandra B, et al. Proposals for a revised staging system. Br J Haematol 1981;48:365-7.

Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute - Sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87(12):4990-7.

Kitada S, Andersen J, Akar S, et al. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses. Blood 1998,91(9):3379-89.

Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.

Lee ET. Statistical methods for survival data analysis. In: Lee ET, editor. Belmont Publication Lifetime Learning; 1980:551.

Cox DR. Regression models and life-tables. J R Stat Soc 1972;34:187-220.

Hopkins A. Survival analysis with covariates - Cox models. In: Dixon WJ, editor. BMDP Statistical Software, 2nd ed. Los Angeles: University of California Press; 1983:557-94.

Minot GB, Isaacs R. Lymphatic leukemia: age, incidence, duration and benefit derived from irradiation. Boston Med Surg J; 1924:191:1-9.

Geisler CH. Chronic lymphocytic leukaemia: newer prognostic approaches in relation to clinical stage. Dan Med Bull 1993;40(suppl 2):190-207.

Jacksic B, Vitale B, Hauptmann E, et al. The roles of age and sex in the prognosis of chronic leukaemias: a study of 373 cases. Br J Cancer 1991;64:345-8.

Hansen MM. Chronic lymphocytic leukemia: clinical studies based on 189 cases followed for a long time. Scand J Haematol 1973;(suppl 18):1-286.

Zippin C, Cutler SJ, Reeves WJ, et al. Survival in chronic lymphocytic leukemia. Blood 1973;42:367-76.

Paolino W, Infelise V, Levis A, et al. Adenosplenomegaly and prognosis in uncomplicated and complicated chronic lymphocytic leukemia: a study of 362 cases. Cancer 1984;54:339-46.

Lee JS, Dixon DO, Kantarjian HM, et al. Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood 1987;69:929-36.

Juliusson G, Oscier DG, Fitchett M, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990;323(suppl 11):720-41.

Boggs DR, Sofferman SA, Wintrobe MM, et al. Factors influencing the duration of survival of patients with chronic lymphocytic leukemia. Am J Med 1966;40:243-54.

Couer P, Gentilhomme O, Morel P, et al. Valeur pronostique de l'hémogramme et du myélogramme initial dans la leucémie lymphoide chronique: étude statistique de 310 observations par la méthode actuarielle. Nouv Rev Fr Hematol 1970;10:566-75.

Geisler C, Ralflaer E, Hansen MM, et al. The bone marrow histological pattern has independent prognostic value in early stage chronic lymphocytic leukaemia. Br J Haematol 1986;62:47-54.

Geisler CH, Larsen JK, Hansen NE, et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 1991;78(suppl 7):1795-802.

Linet MS, Cartwright RA. Chronic lymphocytic leukemia: epidemiology and etiologic findings. Nouv Rev Fr Hematol 1988;30:353-7.

Dameshek W. Chronic lymphocytic leukemia - an accumulative disease of immunologically incompetent lymphocytes. Blood 1967;29:566-84.

Rozman C, Hernandez-Nieto L., Montserrat E, et al. Prognostic significance of bone marrow patterns in chronic lymphocytic leukaemia. Br J Haematol 1981;47:529-37.

Baccarani M, Cavo M, Gobb M, et al. Staging of chronic lymphocytic leukemia. Blood 1982;59:1191-6.

Mandelli F, De Rossi G, Mancini P, et al. Prognosis in chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group. J Clin Oncol 1987;5:398-406.

Rozman C, Montserrat E, Rodriguez-Fernandez JM, et al. Bone marrow histologic pattern: the best single prognostic parameter in chronic lymphocytic leukemia. Blood 1984;64:642-8.

Vallespi T, Montserrat E, Sanz MA. Chronic lymphocytic leukemia: prognostic value of lymphocyte morphological subtypes: a multivariate survival analysis in 146 patients. Br J Hematol 1991;77:478-85.

Downloads

Published

2000-07-07

How to Cite

1.
Faria JR de, Oliveira JSR de, Faria RMD de, Silva MRR, Goihman S, Yamamoto M, Kerbauy J. Prognosis related to staging systems for chronic lymphocytic leukemia. Sao Paulo Med J [Internet]. 2000 Jul. 7 [cited 2025 Oct. 16];118(4):83-8. Available from: https://periodicosapm.emnuvens.com.br/spmj/article/view/2651

Issue

Section

Original Article